IVA vs BIIB: Which Stock is Better?

Side-by-side comparison of Inventiva Sa and Biogen Inc in 2026

Comparison Updated:

IVA

Inventiva Sa

$5.51

BIIB

Biogen Inc

$178.96

Key Metrics Comparison

MetricIVABIIBWinner
Market Cap$1.14B$26.26BBIIB
P/E RatioN/A20.38BIIB
EPS (TTM)$N/A$8.78BIIB
Revenue Growth-0.8%-0.1%BIIB
Gross Margin100.0%78.9%IVA

Analyze IVA

Full quant analysis

Analyze BIIB

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is IVA or BIIB a better investment?

Comparing IVA and BIIB: Inventiva Sa has a market cap of $1.14B while Biogen Inc has $26.26B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between IVA and BIIB?

IVA (Inventiva Sa) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: IVA or BIIB?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: IVA or BIIB?

BIIB has higher revenue growth at -0.1% vs -0.8% for IVA.

Which company is more profitable: IVA or BIIB?

Inventiva Sa (IVA) has higher gross margins at 100.0% compared to 78.9% for BIIB.

Which is the larger company: IVA or BIIB?

Biogen Inc (BIIB) is larger with a market cap of $26.26B compared to $1.14B for IVA.

Should I buy IVA or BIIB in 2026?

Both IVA and BIIB have investment merit. IVA trades at $5.51 while BIIB trades at $178.96. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between IVA and BIIB stock?

Key differences: Market Cap ($1.14B vs $26.26B), P/E Ratio (N/A vs 20.4x), Revenue Growth (-0.8% vs -0.1%), Gross Margin (100.0% vs 78.9%).

Popular Stock Comparisons